These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9096091)

  • 1. Enhancement of [123I]beta-CIT binding in the striatum with clomipramine: is there a serotonin-dopamine interaction?
    Fujita M; Takatoku K; Matoba Y; Nishiura M; Kobayashi K; Inoue O; Nishimura T
    Eur J Nucl Med; 1997 Apr; 24(4):403-8. PubMed ID: 9096091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
    Pirker W; Asenbaum S; Hauk M; Kandlhofer S; Tauscher J; Willeit M; Neumeister A; Praschak-Rieder N; Angelberger P; Brücke T
    J Nucl Med; 2000 Jan; 41(1):36-44. PubMed ID: 10647603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential kinetics of [123I]beta-CIT binding to dopamine and serotonin transporters.
    Fujita M; Takatoku K; Matoba Y; Nishiura M; Kobayashi K; Inoue O; Nishimura T
    Eur J Nucl Med; 1996 Apr; 23(4):431-6. PubMed ID: 8612664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.
    Laruelle M; Baldwin RM; Malison RT; Zea-Ponce Y; Zoghbi SS; al-Tikriti MS; Sybirska EH; Zimmermann RC; Wisniewski G; Neumeyer JL
    Synapse; 1993 Apr; 13(4):295-309. PubMed ID: 7683143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.
    Staley JK; Krishnan-Sarin S; Zoghbi S; Tamagnan G; Fujita M; Seibyl JP; Maciejewski PK; O'Malley S; Innis RB
    Synapse; 2001 Sep; 41(4):275-84. PubMed ID: 11494398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
    Seibyl JP; Laruelle M; van Dyck CH; Wallace E; Baldwin RM; Zoghbi S; Zea-Ponce Y; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo.
    Pirker W; Asenbaum S; Kasper S; Walter H; Angelberger P; Koch G; Pozzera A; Deecke L; Podreka I; Brücke T
    J Neural Transm Gen Sect; 1995; 100(3):247-56. PubMed ID: 8748670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodine-123 labelled nor-beta-CIT binds to the serotonin transporter in vivo as assessed by biodistribution studies in rats.
    Booij J; Knol RJ; Reneman L; de Bruin K; Janssen AG; van Royen EA
    Eur J Nucl Med; 1998 Dec; 25(12):1666-9. PubMed ID: 9871099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [123I]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication.
    Lavalaye J; Knol RJ; de Bruin K; Reneman L; Janssen AG; Booij J
    Eur J Nucl Med; 2000 Mar; 27(3):346-9. PubMed ID: 10774889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of [123I]beta-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primates.
    Scanley BE; al-Tikriti MS; Gandelman MS; Laruelle M; Zea-Ponce Y; Baldwin RM; Zoghbi SS; Hoffer PB; Charney DS; Wang S
    Eur J Nucl Med; 1995 Jan; 22(1):4-11. PubMed ID: 7698153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder.
    Zitterl W; Aigner M; Stompe T; Zitterl-Eglseer K; Gutierrez-Lobos K; Wenzel T; Zettinig G; Hornik K; Pirker W; Thau K
    Neuropsychopharmacology; 2008 Dec; 33(13):3126-34. PubMed ID: 18354388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.
    Brücke T; Asenbaum S; Pirker W; Djamshidian S; Wenger S; Wöber C; Müller C; Podreka I
    J Neural Transm Suppl; 1997; 50():9-24. PubMed ID: 9120429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study.
    Lehto SM; Tolmunen T; Kuikka J; Valkonen-Korhonen M; Joensuu M; Saarinen PI; Vanninen R; Ahola P; Tiihonen J; Lehtonen J
    Neurosci Lett; 2008 Aug; 441(3):291-5. PubMed ID: 18588943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPECT measurement of iodine-123-beta-CIT binding to dopamine and serotonin transporters in Parkinson's disease: correlation with symptom severity.
    Kim SE; Lee WY; Choe YS; Kim JH
    Neurol Res; 1999 Apr; 21(3):255-61. PubMed ID: 10319333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyl 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylate in vitro binding to dopamine and serotonin transporters under "physiological" conditions.
    Laruelle M; Giddings SS; Zea-Ponce Y; Charney DS; Neumeyer JL; Baldwin RM; Innis RB
    J Neurochem; 1994 Mar; 62(3):978-86. PubMed ID: 8113817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging study.
    Shang Y; Gibbs MA; Marek GJ; Stiger T; Burstein AH; Marek K; Seibyl JP; Rogers JF
    J Clin Psychopharmacol; 2007 Feb; 27(1):71-5. PubMed ID: 17224717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects.
    Booij J; de Jong J; de Bruin K; Knol R; de Win MM; van Eck-Smit BL
    J Nucl Med; 2007 Mar; 48(3):359-66. PubMed ID: 17332612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of in vivo binding of [123I]beta-CIT by MK-801 in rat brain.
    Nakano T; Takatoku K; Matoba Y; Iwamoto B; Nishiura M; Inoue O; Nishimura T
    Synapse; 1998 Dec; 30(4):402-8. PubMed ID: 9826232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [123I] beta-CIT, a tracer for dopamine and serotonin re-uptake sites: preparation and preliminary SPECT studies in humans.
    Bergström KA; Kuikka JT; Ahonen A; Vanninen E
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):128-31. PubMed ID: 7632756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.